#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12314	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	589.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1673	1673	T	721	T,C	652,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12314	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	589.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	725	C,G	666,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23076	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3570	644.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1675	1675	A	774	A	715	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23076	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3570	644.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2309	2309	C	759	C	712	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23076	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3570	644.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2383	2383	A	737	A	686	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23076	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3570	644.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2935	2935	C	740	C,A	688,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23076	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3570	644.0	0	HET	.	.	.	C1287T	.	1287	1287	C	1625	1625	C	758	C,T	460,223	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2106	folP	855	855	99.88	folP.l15.c4.ctg.1	1592	131.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1059	1061	AGC	218;218;220	A;G,T;C	208;208,1;210	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5022	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3364	148.8	0	.	p	.	0	G95A	NONSYN	283	285	GGC	561	563	GCC	164;163;161	G;C;C	158;156;155	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5022	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3364	148.8	1	SNP	p	S91F	1	.	.	271	273	TTC	549	551	TTC	167;168;168	T;T;C	159;159;158	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1576	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1228	127.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	381	383	ACC	213;212;213	A,G;C;C	188,1;190;191	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1576	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1228	127.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	579	581	CAC	193;194;193	C;A;C	184;180;179	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1576	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1228	127.0	0	.	p	.	0	A127fs	FSHIFT	379	379	G	645	645	G	197	GCCCC,GCC	189,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1576	mtrR	633	633	99.06	mtrR.l6.c30.ctg.1	1228	127.0	1	SNP	p	G45D	0	.	.	133	135	GGC	399	401	GGC	214;215;216	G;G;C	192;195;194	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	770	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1036	73.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4896	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2959	164.8	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1492	1494	GTC	214;214;217	G;T;C	188;186;193	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4896	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2959	164.8	1	SNP	p	D86N	0	.	.	256	258	GAC	598	600	GAC	199;202;201	G;A;C	189;186;189	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4896	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2959	164.8	1	SNP	p	R87W	0	.	.	259	261	CGT	601	603	CGT	199;198;200	C,T;G;T	184,1;188;188	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4896	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2959	164.8	1	SNP	p	R87I	0	.	.	259	261	CGT	601	603	CGT	199;198;200	C,T;G;T	184,1;188;188	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4896	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2959	164.8	1	SNP	p	S87R	1	.	.	259	261	CGT	601	603	CGT	199;198;200	C,T;G;T	184,1;188;188	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4896	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2959	164.8	1	SNP	p	S88P	0	.	.	262	264	TCC	604	606	TCC	198;199;201	T;C;C	184;188;189	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4104	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2593	157.3	0	.	p	.	0	T169I	NONSYN	505	507	ACC	778	780	ATC	194;194;194	A;T;C	185;183;184	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4104	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2593	157.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1501	1503	GGC	207;207;205	G;G;C	191;191;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1209	1211	GCA	210;211;211	G;C;A	196;194;197	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1212	1214	ATC	214;215;213	A;T;C	200;199;197	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1224	1226	GTG	212;211;210	G;T;G	197;193;194	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1224	1226	GTG	212;211;210	G;T;G	197;193;194	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1728	1730	ACC	192;192;194	A;C;C	171;173;173	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1782	1784	GCG	195;193;194	G;C;G	168;151;157	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1782	1784	GCG	195;193;194	G;C;G	168;151;157	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1905	1907	GGT	152;155;154	G;G;T	145;145;144	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1914	1916	GGC	152;151;150	G,A;G;C	142,1;141;140	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3730	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2294	161.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1932	1934	CCG	140;141;137	C,G;C;G,C	94,6;106;98,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5254	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3094	169.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1604	1606	CCG	190;189;189	C;C,T;G,T	169;173,1;170,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2154	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1703	125.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	487	487	C	165	C	155	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	201	203	AAT	21;20;21	A;A;T	20;19;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	204	206	AAT	21;21;21	A;A;T	21;21;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	228	230	GCA	21;20;20	G;C;A	21;20;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	251	253	GTA	22;22;22	G;T;A	22;22;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	S236N	NONSYN	706	708	AGC	257	259	AAC	22;22;22	A;A;C	22;22;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	.	MULTIPLE	709	711	AAC	261	265	TGGCG	24;24;26;28;31	T;G;G;C;G	24;24;26;28;31	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	D238A	NONSYN	712	714	GAT	267	269	GCT	32;34;34	G;C;T	32;33;33	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	327	329	TTA	65;68;68	T;T;A	55;57;57	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	372	374	CAT	66;65;64	C;A;T	62;61;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	375	377	AGT	64;64;64	A;G;T	60;60;59	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	384	386	TAC	65;64;64	T;A;C	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	309	90.42	porB1a.l15.c17.ctg.2	487	29.4	0	.	p	.	0	R307E	NONSYN	919	921	AGA	474	476	GAA	16;16;16	G;A;A	15;15;15	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	744	746	GGA	206;204;200	G;G;A	194;194;187	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	0	.	p	.	0	.	INDELS	629	630	AA	947	949	TAG	245;249;240	T;A;G	230;239;224	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	0	.	p	.	0	.	MULTIPLE	631	633	TAC	951	954	CAAT	239;237;242;242	C;A;A;T	227;226;230;230	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	0	.	p	.	0	N212fs	FSHIFT	634	634	A	956	956	T	245	T	235	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	1	SNP	p	G120K	0	.	.	358	360	GGT	675	677	GGT	197;198;200	G;G;T	186;186;188	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	1	SNP	p	A121N	0	.	.	361	363	GCC	678	680	GCC	199;199;197	G;C;C	185;187;184	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2682	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1493	177.7	1	SNP	p	A121D	0	.	.	361	363	GCC	678	680	GCC	199;199;197	G;C;C	185;187;184	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9244	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4795	192.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1995	1997	AAT	216;214;214	A,C;A;T	205,1;202;202	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	972	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	980	98.1	1	SNP	p	V57M	1	.	.	169	171	ATG	529	531	ATG	205;202;203	A;T;G	192;188;192	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	M177T	NONSYN	529	531	ATG	888	890	ACG	313;312;314	A;C;G	298;295;300	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	909	911	GAC	271;271;270	G;A;C	268;268;269	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	T190M	NONSYN	568	570	ACG	927	929	ATG	264;265;266	A;T;G	264;263;265	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	L194S	NONSYN	580	582	TTA	939	941	TCA	270;267;268	T;C;A	269;267;268	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	984	986	CAG	243;244;241	C;A;G	240;242;237	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1005	1007	CTT	245;244;242	C;T;T	244;243;241	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1026	1028	AGT	240;242;245	A;G;T	235;235;235	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1095	1097	CCG	345;344;351	C;C,A;G	320;317,1;328	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1197	1199	TCG	364;366;363	T;C;G	343;343;339	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1368	1370	AAA	186;182;182	A;A;A	177;174;173	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1371	1373	AAG	181;179;179	A;A;G	174;173;173	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1386	1388	CAC	162;161;162	C;A;C	160;157;160	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1425	1427	GAA	153;156;158	G;A;A	151;154;156	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1503	1505	ACG	106;107;106	A;C;G	105;106;104	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1554	1556	ATT	138;138;138	A;T;T	132;133;133	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1557	1559	AGT	140;139;139	A;G;T	135;134;133	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1596	1598	CTA	168;169;171	C;T;A	159;161;162	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1638	1640	AAT	119;119;121	A;A;T	115;115;117	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1707	1709	TCA	161;162;166	T;C;A	152;153;157	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1731	1733	ATG	189;189;181	A;T;G	182;183;176	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2025	2027	ACC	430;430;433	A;C;C	396;399;401	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	7134	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2559	277.8	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2121	2123	GAA	398;401;398	G,T;A;A	380,1;383;380	.	Tetracycline resistance
